Implantable cardiac resynchronization therapy devices to monitor heart failure clinical status.
Cardiac resynchronization therapy is a standard therapy for selected patients with heart failure. With advances in technology and storage capacity, the device acts as a convenient platform to provide valuable information about heart failure status in these high-risk patients. Unlike other modalities of investigation which may only allow one-off evaluation, heart failure status can be monitored by device diagnostics including heart rate variability, activity status, and intrathoracic impedance in a continuous basis. These parameters do not just provide long-term prognostic information but also may be useful to predict upcoming heart failure exacerbation. Prompt and early intervention may abort decompensation, prevent hospitalization, improve quality of life, and reduce health care cost. Moreover, this information may be applied to titrate the dosage of medication and monitor response to heart failure treatment. This review will focus on the prognostic and predictive values of heart failure status monitoring provided by these devices.
Fung
Jeffrey Wing-Hong
JW
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Yu
Cheuk-Man
CM
D002304:Cardiac Pacing, Artificial; D002307:Cardiography, Impedance; D017147:Defibrillators, Implantable; D006333:Heart Failure / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D006339:Heart Rate; D006801:Humans; D013318:Stroke Volume; D016277:Ventricular Function, Left; D017725:Ventricular Pressure